Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15498622

Download in:

View as

General Info

PMID
15498622